Home Newsfeeds Baird Downgrades Intel to Neutral, Lowers Price Target to $40

Baird Downgrades Intel to Neutral, Lowers Price Target to $40

Baird analyst Tristan Gerra downgrades Intel (NASDAQ:INTC) from Outperform to Neutral and lowers the price target from $60 to $40.

byBenzinga Newsdesk

July 29, 2022

1 minute read

Baird analyst Tristan Gerra downgrades Intel (NASDAQ:INTC) from Outperform to Neutral and lowers the price target from $60 to $40.

Needham Maintains Buy on Camtek, Raises Price Target to $40

By Benzinga Newsdesk

February 17, 7:47 AM

Needham analyst Charles Shi maintains Camtek (NASDAQ:CAMT) with a Buy and raises the price target from $36 to $40.

CAMT

Inflation Hits South Korean Chip Production; Samsung Braces To Win Market Share Capitalizing On Downturn

By Anusuya Lahiri

December 29, 11:42 AM

South Korea's chip production decreased for a fourth consecutive month in November, sliding 15% year-on-year for its most significant drop since 2009, Statistics Korea found.

HXSCL

WD-40 Company Increases Quarterly Dividend From $0.83 To $0.88 Per Share

By Benzinga Newsdesk

December 12, 4:40 PM

WD-40 Company (NASDAQ:WDFC) today announced that its board of directors declared on Tuesday, December 12, 2023 a quarterly dividend of $0.88 per share reflecting an increase of 6 percent compared to the previous

WDFC

Why Lipocine Stock Is Moving Higher Today?

By Vandana Singh

July 27, 12:22 PM

Lipocine Inc (NASDAQ: LPCN) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the

LPCN

Baird Downgrades Intel to Neutral, Lowers Price Target to $40

Related Posts

Needham Maintains Buy on Camtek, Raises Price Target to $40

Inflation Hits South Korean Chip Production; Samsung Braces To Win Market Share Capitalizing On Downturn

WD-40 Company Increases Quarterly Dividend From $0.83 To $0.88 Per Share

Why Lipocine Stock Is Moving Higher Today?